Physician profile
Colleen E Killian
NPI 1992095129
$1,939.67
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2020: $36.93 · 2021: $213 · 2022: $564 · 2023: $433 · 2024: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $443.95 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $280.24 | 2021-2024 | |
| Aspira Women'S Health INC | $134.29 | 2022 | |
| Organon LLC | $78.85 | 2022-2024 | Nexplanon |
| Merz North America, INC. | $75.00 | 2023 | Xeomin |
| Bayer Healthcare Pharmaceuticals INC. | $71.24 | 2019-2023 | |
| Daiichi Sankyo INC. | $65.59 | 2019 | |
| Evofem Biosciences, INC. | $64.99 | 2021-2023 | Phexxi |
| Avion Pharmaceuticals | $60.86 | 2019-2023 | NP Thyroid 60 |
| Duchesnay USA Incorporated | $60.46 | 2019 | |
| Revance Therapeutics, INC. | $55.56 | 2024 | Daxxify |
| Boston Scientific Corporation | $54.32 | 2019-2024 | Obtryx System - Curved |
| Astellas Pharma US INC | $53.00 | 2019 | |
| Therapeuticsmd, INC. | $52.63 | 2019-2022 | |
| Exeltis, USA INC. | $51.63 | 2022-2023 | Slynd |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $35.89 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $33.77 | 2023 | Caldolor |
| Davol INC. | $30.77 | 2019-2022 | |
| Myovant Sciences INC. | $29.35 | 2022 | |
| Roche Diagnostics Corporation | $29.27 | 2019 | |
| Merck Sharp & Dohme LLC | $26.39 | 2019 | |
| Meditrina | $24.89 | 2022-2023 | |
| Agile Therapeutics, INC. | $19.49 | 2024 | Twirla |
| Hologic Sales and Service, LLC | $15.82 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.34 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.76 | 2022 | |
| Ascend Therapeutics US, LLC | $13.92 | 2024 | |
| Mylan Pharmaceuticals INC. | $13.07 | 2019 | |
| Pfizer INC. | $12.92 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.29 | 2019 | |
| Channel Medsystems, INC. | $9.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Killian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.